Protective effect of chitosan oligosaccharides against FcεRI-mediated RBL-2H3 mast cell activation

Process Biochemistry

Volumn 47, Issue 2, 2012, Pages 327-330

  Vo, Thanh Sang ^a   Kim, Jung Ae ^a   Ngo, Dai Hung ^a   Kong, Chang Suk ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Chitosan oligosaccharides; Fc RI; Histamine; Intracellular Ca 2+; Mast cells

Indexed keywords

ALLERGIC REACTIONS; ALLERGIC RESPONSE; CELL ACTIVATION; CHITOSAN OLIGOSACCHARIDE; DEGRANULATION; DOSE-DEPENDENT MANNER; HEXOSAMINIDASE; HISTAMINE; IMMUNOGLOBULIN E; INHIBITORY ACTIVITY; INTRACELLULAR CA; MAST CELLS; PROTECTIVE EFFECTS; SERUM ALBUMIN;

BODY FLUIDS; CHITOSAN; OLIGOSACCHARIDES;

CELLS;

BOVINAE;

EID: 84855760350     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2011.10.036     Document Type: Article

References (24)

1. J.M. Brown, T.M. Wilson, and D.D. Metcalfe The mast cell and allergic diseases: role in pathogenesis and implications for therapy Clin Exp Allergy 38 2008 4 18 (Pubitemid 350233400)
2. D. von Bubnoff, N. Novak, S. Kraft, and T. Bieber The central role of FcεRI in allergy Clin Exp Dermatol 28 2003 184 187
3. R.P. Siraganian Mast cell signal transduction from the high-affinity IgE receptor Curr Opin Immunol 15 2003 639 646 (Pubitemid 37434071)
4. R. Naclerio Clinical manifestations of the release of histamine and other inflammatory mediators J Allergy Clin Immunol 103 1999 382 385
5. Y. Li, S.H. Lee, Q.T. Le, M.M. Kim, and S.K. Kim Anti-allergic effects of phlorotannins on histamine release via binding inhibition between IgE and FcεRI J Agric Food Chem 56 2008 12073 12080
6. S.K. Kim, and N. Rajapakse Enzymatic production and biological activities of chitosan oligosaccharides (COS): a review Carbohydr Polym 62 2005 357 368 (Pubitemid 41745217)
7. S.Y. Chae, M.K. Jang, and J.W. Nah Influence of molecular weight on oral absorption of water soluble chitosans J Control Release 102 2005 383 394 (Pubitemid 40093761)
8. T.S. Vo, and S.K. Kim Potential anti-HIV agents from marine resources: an overview Mar Drugs 8 2010 2871 2892
9. B.B. Aam, E.B. Heggset, A.L. Norberg, M. Sørlie, K.M. Vrum, and V.G. Eijsink Production of chitooligosaccharides and their potential applications in medicine Mar Drugs 8 2010 1482 1517
10. T.S. Vo, C.S. Kong, and S.K. Kim Inhibitory effects of chitooligosaccharides on degranulation and cytokine generation in rat basophilic leukemia RBL-2H3 cells Carbohydr Polym 84 2011 649 655
11. E. Passante, and N. Frankish The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell Inflamm Res 58 2009 737 745
12. A. Solomon, and F. Levi-Schaffer Mast cells beyond allergy: their role in fibrotic conditions Biomed Rev 6 1996 69 74 (Pubitemid 27141936)
13. K. Nishida, S. Yamasaki, Y. Ito, K. Kabu, K. Hattori, and T. Tezuka FcεRI-mediated mast cell degranulation requires calcium-independent micro-tubule-dependent translocation of granules to the plasma membrane J Cell Biol 170 2005 115 126 (Pubitemid 40994101)
14. M. Jutel, M. Akdis, and C.A. Akdis Histamine, histamine receptors and their role in immune pathology Clin Exp Allergy 39 2009 1786 1800
15. M. Wendeler, and K. Sandhoff Hexosaminidase assays Glycoconjug J 26 2009 945 952
16. S. Aketani, R. Teshima, Y. Umezawa, and J. Sawada Correlation between cytosolic calcium concentration and degranulation in RBL-2H3 cells in the presence of various concentrations of antigen-specific IgEs Immunol Lett 75 2001 185 189 (Pubitemid 32166773)
17. M. Matsubara, S. Masaki, K. Ohmori, A. Karasawa, and K. Hasegawa Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells Biochem Pharmacol 67 2004 1315 1326 (Pubitemid 38315097)
18. 2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells Int Immunopharmacol 10 2010 769 776
19. R. Molfetta, G. Peruzzi, A. Santoni, and R. Paolini Negative signals from FcεRI engagement attenuate mast cell functions Arch Immunol Ther Exp (Warsz) 55 2007 219 229 (Pubitemid 47262711)
20. M. Yamaguchi, C.S. Lantz, H.C. Oettgen, I.M. Katona, T. Fleming, and I. Miyajima IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions J Exp Med 185 1997 663 672 (Pubitemid 27098151)
21. S.Y. Shim, J.S. Choi, and D.S. Byun Kaempferol isolated from Nelumbo nucifera stamens negatively regulates FcεRI expression in human basophilic KU812F cells J Microbiol Biotechnol 19 2009 155 160
22. N. Kageyama-Yahara, Y. Suehiro, F. Maeda, S. Kageyama, J. Fukuoka, and T. Katagiri Pentagalloylglucose down-regulates mast cell surface FcepsilonRI expression in vitro and in vivo FEBS Lett 584 2010 111 118
23. Y. Fujimura, H. Tachibana, and K. Yamada Lipid raft-associated catechin suppresses the FcεRI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2 FEBS Lett 556 2004 204 210 (Pubitemid 38058580)
24. C. Nishiyama, T. Yokota, K. Okumura, and C. Ra The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor α-chain gene J Immunol 163 1999 623 630 (Pubitemid 29328065)